These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22951004)

  • 1. Scrotal metastasis from a nonmuscle-infiltrative bladder cancer: a surprising clinical evolution.
    Nouhaud FX; Di Fiore F; Noël N; Gobet F; Pfister C
    Urology; 2012 Oct; 80(4):e37-8. PubMed ID: 22951004
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmacytoid urothelial carcinoma of the bladder.
    Kohno T; Kitamura M; Akai H; Takaha M; Kawahara K; Oka T
    Int J Urol; 2006 Apr; 13(4):485-6. PubMed ID: 16734884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urothelial bladder carcinoma metastasising to the scrotum mimicking primary extra-mammary Paget's disease.
    Gulavita P; Mai KT
    Pathology; 2014 Apr; 46(3):256-7. PubMed ID: 24614713
    [No Abstract]   [Full Text] [Related]  

  • 4. Stage pT0 after radical cystectomy: are all patients equal?
    Chromecki TF; Cha EK; Shariat SF;
    Eur Urol; 2011 Sep; 60(3):603-4. PubMed ID: 21665358
    [No Abstract]   [Full Text] [Related]  

  • 5. Urothelial carcinoma with orbital metastasis.
    SooHoo JR; Gonzalez MO; Siomos VJ; Durairaj VD
    Urology; 2012 Oct; 80(4):e45-6. PubMed ID: 22857742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?
    Tsai YS; Tzai TS; Chow NH
    Urol Int; 2007; 79(3):210-6. PubMed ID: 17940352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cutaneous metastasis of bladder cancer].
    Moreno E; Ojados F; Pastor FA; Trigueros M
    Arch Esp Urol; 1987 May; 40(4):279-80. PubMed ID: 3632056
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine.
    Krajewski KM; Fougeray R; Bellmunt J; Pons F; Schutz FA; Rosenberg JE; Salhi Y; Choueiri TK
    Eur J Cancer; 2012 Jul; 48(10):1495-502. PubMed ID: 22176867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term response in advanced bladder cancer involving the use of temsirolimus and vinflunine after platin resistance.
    Gerullis H; Ecke TH; Janusch B; Arndt C; Heidari M; Oniani J; Otto T
    Anticancer Drugs; 2011 Oct; 22(9):940-3. PubMed ID: 21642839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant activity of single agent vinorelbine against small-cell cancer of the bladder as second line chemotherapy: a case series and review of the literature.
    June RR; Dougherty DW; Reese CT; Harpster LE; Hoffman SL; Drabick JJ
    Urol Oncol; 2012; 30(2):192-5. PubMed ID: 20363163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micropapillary urothelial carcinoma: clinico-pathologic review.
    Perepletchikov AM; Parwani AV
    Pathol Res Pract; 2009; 205(12):807-10. PubMed ID: 19767154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can patient selection for bladder preservation be based on response to chemotherapy?
    Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M
    Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cT2 bladder cancer: a good candidate for radiotherapy combined with cisplatin for bladder preservation.
    Hara T; Nishijima J; Miyachika Y; Yamamoto Y; Sakano S; Matsuyama H
    Jpn J Clin Oncol; 2011 Jul; 41(7):902-7. PubMed ID: 21616918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
    Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinflunine.
    Prescrire Int; 2011 Jan; 20(112):11-3. PubMed ID: 21462785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle metastasis mimicking a shoulder effusion.
    Journeay WS; Omar A; Carette S
    J Rheumatol; 2013 Sep; 40(9):1616. PubMed ID: 23996995
    [No Abstract]   [Full Text] [Related]  

  • 17. Smoothelin immunohistochemistry is a useful adjunct for assessing muscularis propria invasion in bladder carcinoma.
    Bovio IM; Al-Quran SZ; Rosser CJ; Algood CB; Drew PA; Allan RW
    Histopathology; 2010 Jun; 56(7):951-6. PubMed ID: 20636795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the evaluation and management of lymph node involvement in urothelial carcinoma of the bladder.
    Siddiqui MM; Feldman AS
    Expert Rev Anticancer Ther; 2010 Dec; 10(12):1855-9. PubMed ID: 21110750
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of a sporadic malignant peripheral nerve sheath tumor of the urinary bladder with concomitant in situ urothelial carcinoma treated by transuretheral resection.
    Sari A; Bal K; Tunakan M; Ozturk C
    Indian J Pathol Microbiol; 2011; 54(1):147-9. PubMed ID: 21393901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
    Nuhn P; May M; Sun M; Fritsche HM; Brookman-May S; Buchner A; Bolenz C; Moritz R; Herrmann E; Burger M; Tilki D; Trojan L; Perrotte P; Haferkamp A; Hohenfellner M; Wieland WF; Müller SC; Karakiewicz PI; Bastian PJ
    Eur Urol; 2012 Jan; 61(1):58-64. PubMed ID: 21840642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.